» Articles » PMID: 17386339

Health Insurance Status and Hypertension Monitoring and Control in the United States

Overview
Journal Am J Hypertens
Date 2007 Mar 28
PMID 17386339
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In this study, we examined whether insurance status (private, Medicare, Medicaid, no insurance) was associated with the odds of blood pressure (BP) monitoring and control.

Methods: We used data from the National Health and Nutrition Examination Surveys (NHANES) conducted in 1999 through 2002, defining hypertension as either self-report of elevated BP or an elevated BP value on examination. We conducted multivariate analyses adjusting for age, income, race/ethnicity, body mass index, and medical comorbidities.

Results: Among all hypertensive participants, only 58% of the uninsured had a BP check within 6 months, compared to 82% of the privately insured. Overall, uninsured individuals (adjusted odds ratio 0.63, 95% CI 0.44-0.92) were at lower odds of adequate BP control than the privately insured. Among treated participants, the uninsured were at lower odds of adequate control (adjusted OR 0.42, 95% CI 0.23-0.73) than the privately insured. Among participants who self-reported hypertension but were not taking antihypertensive medications, the odds of elevated BP did not differ by insurance status. No differences in BP control were observed for participants with Medicare or Medicaid compared to those with private insurance, in any comparisons.

Conclusions: Lack of insurance is associated with lower rates of BP control among treated hypertensives, whereas the odds of elevated BP are similar among untreated hypertensives with different insurance status. Variation in BP control between the uninsured and privately insured with hypertension is likely related to differences in appropriate treatment intensification or adherence, rather than differences in rates of treatment initiation.

Citing Articles

Consideration of inequalities in effectiveness trials of mHealth applications - a systematic assessment of studies from an umbrella review.

Abdelmalak N, Burns J, Suhlrie L, Laxy M, Stephan A Int J Equity Health. 2024; 23(1):181.

PMID: 39261871 PMC: 11389088. DOI: 10.1186/s12939-024-02267-4.


The impact of health insurance on hypertension care: a household fixed effects study in India.

Feng Z, Chen Q, Jiao L, Ma X, Atun R, Geldsetzer P BMC Public Health. 2024; 24(1):2287.

PMID: 39175008 PMC: 11342611. DOI: 10.1186/s12889-024-19759-1.


Adherence to antihypertensives in the United States: A comparative meta-analysis of 23 million patients.

Dean Y, Motawea K, Shebl M, Elawady S, Nuhu K, Abuzuaiter B J Clin Hypertens (Greenwich). 2024; 26(4):303-313.

PMID: 38488773 PMC: 11007819. DOI: 10.1111/jch.14788.


Prescribing patterns and pharmacoeconomic analysis of antihypertensive drugs in South Indian population: A cross-sectional study.

Shanmugapriya S, Thangavelu S, Shukkoor A, Janani P, Monisha R, Scaria V Perspect Clin Res. 2023; 14(3):114-122.

PMID: 37554244 PMC: 10405530. DOI: 10.4103/picr.picr_122_22.


Determinants of self-reported hypertension among women in South Africa: evidence from the population-based survey.

Ntenda P, El-Meidany W, Tiruneh F, Motsa M, Nyirongo J, Chirwa G Clin Hypertens. 2022; 28(1):39.

PMID: 36376985 PMC: 9664601. DOI: 10.1186/s40885-022-00222-5.